Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Histogenics Files For U.S. Patent Titled ‘NEOCARTILAGE CONSTRUCTS USING UNIVERSAL CELLS’

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220220265900%22.PGNR.&OS=DN/20220265900
byBenzinga Newsdesk
August 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220220265900%22.PGNR.&OS=DN/20220265900

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cuentas, Inc. CEO Unveils Accomplishments Of 2023: Unprecedented Shareholder Support In Proxy Vote And Shares Visionary Fiscal Year 2024 Plans; Cuentas Wields A Majority Stake In Our Upcoming Tampa Project, Poised To Break Ground In 2024

By Benzinga Newsdesk
January 8, 11:15 AM
Cuentas, Inc. Unveils Empowering Shareholder Letter: Triumph in Proxy Votes, Surging Revenue, and Elevated Gross Margins Steal the Spotlight, Reinforcing Dominance in Integrated Mobile, Fintech, and Real Estate

CUEN